Diplomat Announces 3rd Quarter Financial Results; Updates 2019 Guidance 3rd Quarter Revenue of $1,301 Million, compared to $1,373 Million, Net Loss of $177 Million, compared to Net Income of $0.2 Million, Adjusted EBITDA of $11.5 Million, compared to $41.9 Million PR Newswire FLINT, Mich., Nov. 12, 2019 FLINT, Mich. , Nov. 12, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy and infusion services, announced financial...